India-based drug manufacturer receives green signal from the US FDA

Diabetic patients around the globe will soon be able to get medicines manufactured in India

It has to be admitted that in the current era, everyone has a very busy life and many people have a sedentary lifestyle. Many even do not maintain a healthy diet due to which they face various health issues. These habits often lead to diseases like high blood pressure and diabetes.
Doctors and the medical fraternity all over the world are trying their level best to provide the best treatment to diabetic patients to help them recover quickly. Positive news is there in this context.
Indian drug firm Zydus Cadila has received approval from the United States Food and Drug Administration to market Sitagliptin.
It was on October 31, 2020, when Zydua Cadila filed a new drug application with the United States Food and Drug Administration seeking approval to market Silagliptin base 25, 50 and 100mg tablets.
Sitagliptin is a medicine that is used to treat diabetic patients. The brand name of Sitagliptin is Junavia. These medicines belong to a group called VALSS (in short form) which includes other medicines namely- Vildagliptin, Alogliptin, Linagliptin, Saxagliptin and Sitagliptin. 
The logo of Zydus Cadila
Image: The logo of Zydus Cadila
Sitagliptin or Junavia is given to the diabetic patients as per their needs in doses of 25mg, 50mg and 100mg. Sometimes it is given as an individual medicine and sometimes it is combined with other medicines like Metformin or Sulfonylurea.
It was on October 31, 2020, when Zydua Cadila filed a new drug application with the United States Food and Drug Administration seeking approval to market Silagliptin base 25, 50 and 100 mg tablets. It was announced on September 2, 2021, when the NDA received tentative approval upon completion of the first review cycle.
Zydus Cadila or Cadila Health Limited is an Indian Multinational Pharmaceutical Company based in Ahmedabad manufacturing generic drugs. Moreover, Zydus is also involved in other healthcare services like the production of small molecule drugs, biological therapeutics and vaccines.



Be the first to start a discussion here. Sign-in to write a comment now!